A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids

被引:39
|
作者
Fowler, Jonas L. [1 ,2 ]
Ang, Lay Teng [1 ]
Loh, Kyle M. [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Stanford UC Berkeley Siebel Stem Cell Inst, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med,Maternal & Child Hlth Res Inst, Wu Tsai Neurosci Inst,BioX,Diabet Res Ctr, Dept Dev Biol,Canc Inst,Cardiovasc Inst,ChEM H, Stanford, CA 94305 USA
关键词
developmental biology; germ layer; organoid; pluripotent stem cell; stem cell differentiation; PRIMITIVE STREAK FORMATION; IN-VITRO; HUMAN ES; DIRECTED DIFFERENTIATION; PANCREATIC PROGENITORS; NEURAL PROGENITORS; CEREBRAL ORGANOIDS; FUNCTIONAL-NEURONS; MOUSE EMBRYO; HUMAN LIVER;
D O I
10.1002/wdev.368
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Too many choices can be problematic. This is certainly the case for human pluripotent stem cells (hPSCs): they harbor the potential to differentiate into hundreds of cell types; yet it is highly challenging to exclusively differentiate hPSCs into a single desired cell type. This review focuses on unresolved and fundamental questions regarding hPSC differentiation and critiquing the identity and purity of the resultant cell populations. These are timely issues in view of the fact that hPSC-derived cell populations have or are being transplanted into patients in over 30 ongoing clinical trials. While many in vitro differentiation protocols purport to "mimic development," the exact number and identity of intermediate steps that a pluripotent cell takes to differentiate into a given cell type in vivo remains largely unknown. Consequently, most differentiation efforts inevitably generate a heterogeneous cellular population, as revealed by single-cell RNA-sequencing and other analyses. The presence of unwanted cell types in differentiated hPSC populations does not portend well for transplantation therapies. This provides an impetus to precisely control differentiation to desired ends-for instance, by logically blocking the formation of unwanted cell types or by overexpressing lineage-specifying transcription factors-or by harnessing technologies to selectively purify desired cell types. Conversely, approaches to differentiate three-dimensional "organoids" from hPSCs intentionally generate heterogeneous cell populations. While this is intended to mimic the rich cellular diversity of developing tissues, whether all such organoids are spatially organized in a manner akin to native organs (and thus, whether they fully qualify as organoids) remains to be fully resolved. This article is categorized under: Adult Stem Cells > Tissue Renewal > Regeneration: Stem Cell Differentiation and Reversion Gene Expression > Transcriptional Hierarchies: Cellular Differentiation Early Embryonic Development: Gastrulation and Neurulation
引用
收藏
页数:23
相关论文
共 50 条
  • [41] A method of generating alveolar organoids using human pluripotent stem cells
    Yamamoto, Yuki
    Korogi, Yohei
    Hirai, Toyohiro
    Gotoh, Shimpei
    HUMAN PLURIPOTENT STEM CELL DERIVED ORGANOID MODELS, 2020, 159 : 115 - +
  • [42] Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy
    Zhang, Teng
    Qian, Cheng
    Song, Mengyao
    Tang, Yu
    Zhou, Yueke
    Dong, Guanglu
    Shen, Qiuhong
    Chen, Wenxing
    Wang, Aiyun
    Shen, Sanbing
    Zhao, Yang
    Lu, Yin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
  • [43] In vitro generation of human pluripotent stem cell derived lung organoids
    Dye, Briana R.
    Hill, David R.
    Ferguson, Michael A. H.
    Tsai, Yu-Hwai
    Nagy, Melinda S.
    Dyal, Rachel
    Wells, James M.
    Mayhew, Christopher N.
    Nattiv, Roy
    Klein, Ophir D.
    White, Eric S.
    Deutsch, Gail H.
    Spence, Jason R.
    ELIFE, 2015, 4 : 1 - 25
  • [44] Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine
    Lee, Hana
    Son, Mi-Young
    INTERNATIONAL JOURNAL OF STEM CELLS, 2021, 14 (01) : 9 - 20
  • [45] Differentiation of human pluripotent stem cells into β-cells: Potential and challenges
    Quiskamp, Nina
    Bruin, Jennifer E.
    Kieffer, Timothy J.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 29 (06) : 833 - 847
  • [46] Identification of stable reference genes in differentiating human pluripotent stem cells
    Holmgren, Gustav
    Ghosheh, Nidal
    Zeng, Xianmin
    Bogestal, Yalda
    Sartipy, Peter
    Synnergren, Jane
    PHYSIOLOGICAL GENOMICS, 2015, 47 (06) : 232 - 239
  • [47] Human Pluripotent Stem Cell-derived Organoids Yield Microvascular-like Endothelial Cells
    Majid, Qasim A.
    Talman, Virpi
    Harding, Sian
    Foldes, Gabor
    CIRCULATION RESEARCH, 2023, 133
  • [48] Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells
    Morizane, Ryuji
    Bonventre, Joseph V.
    NATURE PROTOCOLS, 2017, 12 (01) : 195 - 207
  • [49] Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells
    Ryuji Morizane
    Joseph V Bonventre
    Nature Protocols, 2017, 12 : 195 - 207
  • [50] A FACILE METHOD TO GENERATE CEREBRAL ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS
    Simorgh, Susan
    Mousavi, Seyed Ahmad
    To, San Kit
    Pasque, Vincent
    Wierda, Keimpe
    Vervliet, Tim
    Yeganeh, Meghdad
    Pooyan, Paria
    Chai, Yoke Chin
    Verfaillie, Catherine
    Baharvand, Hossein
    EXCLI JOURNAL, 2023, 22 : 1055 - 1076